- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
During the summer months INBT will be organizing a series of seminars which will focus on professional development for students with an interest in nanobiotechnology. Topics that will be addressed are intellectual property, venture capital, and research ethics.
A limited number of seats are available. Interested students and/or faculty members need to send a response to Ashanti Edwards, Educational Program Coordinator for INBT, at or (410) 516 6572, or visit her in Maryland Hall 214. Seats are awarded on a first response first serve base.
Location: Maryland Hall 109
Date: See Description below
Invention Protection & Licensing
Date: June 13, 2007
Subject: Intellectual Property
Presenter: Jane Kuhl
Abstract: This seminar will cover: how to properly document and report your inventions, the JHU IP policy, types of patents and licenses, negotiating licenses, typical licensing terms, patent infringement, and pursuing patent infringers. Federal regulations and JHU policies related to Hopkins inventions will be covered including how inventors can obtain rights to their inventions if they are interested in spinning-out their technology into a start-up company.
Bio: Jane Kuhl has a BS in Physics and an MS in Electrical Engineering from Georgia Institute of Technology and is currently the Director of Intellectual Property Programs for the Johns Hopkins Homewood Schools. She was Head of the Technology Transfer Office and Exhibits/Marketing groups of the US Naval Research Laboratory (NRL) in Washington DC for approximately 3 years. NRL is the Department of the Navy's corporate laboratory and has an annual research funding budget of approximately $1Billion. Before joining NRL, Jane spent more than 20 years at AT&T and its spin-offs, Lucent Technologies and Agere Systems.
Ethical Issues in Nanobiotechnology
Date(s): June 27, 2007 and July 25, 2007
Subject: Ethics in research & Case studies of biomedical ethics.
Presenter: Glenn Rahmoeller
Abstract: Ethics addresses the social concerns of technology. In this class we will learn (a) two important ethical theories and how to apply them, (b) what it means to be a professional, (c) what our professional obligations are to our employers and to society, (d) and how this all relates to our particular roles as engineers and scientists in the field of nanobiotechnology. We will discuss a specific application of nanotechnology to medicine and answer the following questions. What are the expected benefits of the technology? What are the possible risks? What are our obligations to educate society about this technology and to safeguard society from its potential harm?
Bio: Glenn Rahmoeller is a biomedical engineer with over 30 years of experience at the NIH, Director of Cardiovascular Devices at the FDA, and a consultant to the medical devices industry. He has been teaching applied ethics for university students and the medical devices industry since 1998. He is a senior lecturer in the Honors Program at the University of Maryland and a lecturer in the Department of Materials Science and Engineering at Johns Hopkins University.
Venture Capital in Nanobiotechnology
Date: July 10, 2007
Subject: Venture capital
Presenter: Justin Klein
Abstract: Through case studies we give an overview of the investment process, how you select companies/technologies, what you hope to get out of it, as well as insight into venture capitalism as a career path.
Bio: Justin Klein is a Senior Associate at New Enterprise Associates. He joined NEA's healthcare team in 2006 and focuses on medical device, biopharmaceutical, specialty pharmaceutical, and healthcare services company investments. He worked for the Duke University Health System, reporting directly to the CEO and the COO of Duke University Hospital on health system strategy, finance and clinical service unit operations. In addition, he has worked at Latham & Watkins LLP in Menlo Park, where he assisted life sciences companies on numerous licensing transactions, regulatory and corporate securities matters. Justin currently serves as a member of the Board of Trustees of Duke University, and has previously served on Duke University Medical Center's Institutional Review Board. Justin concurrently earned his MD from the Duke University School of Medicine and his JD from Harvard Law School. He received his AB in Economics and his BS in Biological Anthropology and Anatomy from Duke University.
Pending: (check back for updates)
Date: August 8, 2007
Presenter: John Schmidt
Bio: John Schmidt is Director of CBE Defense Systems at Northrop Grumman Corporation, a $30 billion global defense and technology company whose 122,000 employees provide innovative systems, products, and solutions in information and services, electronics, aerospace and shipbuilding to government and commercial customers worldwide.
About The Institute for NanoBioTechnology at John Hopkins University
The Institute for NanoBioTechnology at Johns Hopkins University will revolutionize health care by bringing together internationally renowned expertise in medicine, engineering, the sciences, and public health to create new knowledge and groundbreaking technologies.
INBT programs in research, education, outreach, and technology transfer are designed to foster the next wave of nanobiotechnology innovation.
Approximately 140 faculty are affiliated with INBT and are also members of the following Johns Hopkins institutions: Krieger School of Arts and Sciences, Whiting School of Engineering, School of Medicine, Bloomberg School of Public Health, and Applied Physics Laboratory.
Research at INBT is concentrated in three core areas:
* Diagnostics & Therapeutics
Research at INBT focused in this area includes biosensors, drug and gene therapy, DNA nanoparticles, functional tissue engineering, diagnostic imaging, and protein engineering.
* Health and the Environment
Research at INBT includes nano-toxicological studies, public health and environmental effects of nanotechnology, and environmental remediation using nanotechnology.
* Cellular & Molecular Dynamics
Research at INBT focused in this area includes cell signaling and interactions, molecular imaging, protein folding, and real-time visualization inside cells.
For more information, please click here
* Institute for NanoBioTechnology
214 Maryland Hall
3400 North Charles Street
Baltimore, MD 21218
* Phone: (410) 516-3423
* Fax: (410) 516-2355
Copyright © John Hopkins UniversityIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Iran to hold intl. school on application of nanomaterials in medicine September 20th, 2016
March 2016; 6th Int'l Conference on Nanostructures in Iran July 29th, 2015
PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014
Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016
New Agricultural Research Center Debuts at UCF October 12th, 2016
Forge Nano raises $20 million in Series A Funding: Nano coating technology innovator Forge Nano will use funding to expand manufacturing capacity and grow Lithium-Ion battery opportunities November 3rd, 2016
Leti IEDM 2016 Paper Clarifies Correlation between Endurance, Window Margin and Retention in RRAM for First Time: Paper Presented at IEDM 2016 Offers Ways to Reconcile High-cycling Requirements and Instability at High Temperatures in Resistive RAM December 6th, 2016
Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016
IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016
Cutting-edge nanotechnologies are breaking into industries November 18th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016